Botox has now been approved by the U.S. Food and Drug Administration for the treatment of excessive armpit sweating, a condition known medically as hyperhydrosis. Botox is now an important new treatment option for patients living with severe armpit sweating that is not well controlled with topical agents. In the clinical trials that led to the FDA's approval, 86% of treated patients showed a significant reduction in armpit sweating. When injected into the armpits, Botox acts by blocking the release of sweat by the sweat glands, resulting in a significant reduction in sweating within three to seven days. On average, patients have maintained their results for over six months. Dr. Amerian is pleased to announce that she is making this treatment option available to her patients who are bothered by excessive armpit sweating.